Daniel Tan
0000-0002-6514-6786
National Cancer Centre Singapore
2 papers found
Refreshing results…
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis
Missing publications? Search for publications with a matching author name.